These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 15201935

  • 1. [Biological modulation of IL-1 activity: role and development of its natural inhibitor IL-1Ra].
    Dayer JM.
    Reumatismo; 2004; 56(1 Suppl 1):3-8. PubMed ID: 15201935
    [Abstract] [Full Text] [Related]

  • 2. Evidence for the biological modulation of IL-1 activity: the role of IL-1Ra.
    Dayer JM.
    Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S14-20. PubMed ID: 14989424
    [Abstract] [Full Text] [Related]

  • 3. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J, Hayer S, Tohidast-Akrad M, Bergmeister H, Redlich K, Feige U, Dunstan C, Kollias G, Steiner G, Smolen J, Schett G.
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [Abstract] [Full Text] [Related]

  • 4. Modulation of osteoclast-activating factor activity of multiple myeloma bone marrow cells by different interleukin-1 inhibitors.
    Torcia M, Lucibello M, Vannier E, Fabiani S, Miliani A, Guidi G, Spada O, Dower SK, Sims JE, Shaw AR, Dinarello CA, Garaci E, Cozzolino F.
    Exp Hematol; 1996 Jul; 24(8):868-74. PubMed ID: 8690044
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer.
    Wang HJ, Yu CL, Kishi H, Motoki K, Mao ZB, Muraguchi A.
    Chin Med J (Engl); 2006 Aug 20; 119(16):1365-73. PubMed ID: 16934183
    [Abstract] [Full Text] [Related]

  • 8. Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes.
    François M, Richette P, Tsagris L, Fitting C, Lemay C, Benallaoua M, Tahiri K, Corvol MT.
    Arthritis Rheum; 2006 Apr 20; 54(4):1233-45. PubMed ID: 16572457
    [Abstract] [Full Text] [Related]

  • 9. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis.
    Dayer JM.
    Rheumatology (Oxford); 2003 May 20; 42 Suppl 2():ii3-10. PubMed ID: 12817089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist.
    Smeets RL, Joosten LA, Arntz OJ, Bennink MB, Takahashi N, Carlsen H, Martin MU, van den Berg WB, van de Loo FA.
    Arthritis Rheum; 2005 Jul 20; 52(7):2202-11. PubMed ID: 15986350
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Role of matrix metalloproteinase-3 in joint destruction in rheumatoid arthritis].
    Sugiyama E.
    Clin Calcium; 2007 Apr 20; 17(4):528-34. PubMed ID: 17404481
    [Abstract] [Full Text] [Related]

  • 15. Updated consensus statement on biological agents, specifically tumour necrosis factor {alpha} (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2005.
    Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Bijlsma JW, Dougados M, Emery P, Keystone EC, Klareskog L, Mease PJ.
    Ann Rheum Dis; 2005 Nov 20; 64 Suppl 4(Suppl 4):iv2-14. PubMed ID: 16239380
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. RANKL-stimulated osteoclast-like cell formation in vitro is partially dependent on endogenous interleukin-1 production.
    Lee SK, Gardner AE, Kalinowski JF, Jastrzebski SL, Lorenzo JA.
    Bone; 2006 May 20; 38(5):678-85. PubMed ID: 16309985
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Interleukin-1 receptor antagonist intervenes in signaling between different types of synoviocytes in rats with adjuvant arthritis.
    Zheng YQ, Wei W, Dai M, Zhu L, Jia XY, Wang Y.
    Acta Pharmacol Sin; 2006 Jan 20; 27(1):111-8. PubMed ID: 16364217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.